Huadong Medicine ( Hangzhou ) Bailing Biotechnology Co., Ltd was found in 2013, which is the whole subsidiary of Huadong Medicine. The company specializes in the R&D medicine and import and export of goods and technology. Jiangdong phase I project is mainly used to ferment cordyceps sinensis powder for production expansion. The actual total investment of the project is about 800 million yuan, which was completed in June 2016 and has passed GMP certification and put into production on schedule. The smooth production of the first phase of this project has strongly supported the future continuous growth of the company's flagship product Bailing capsule.

In 2017, the company invested in the second phase of Jiangdong project, mainly used in the production base, pilot R&D platform and its supporting storage system, power utility system, environmental protection system, quality inspection r&d center, office administration center of acarbose apis and preparations, polypeptide diabetes drugs, super antibiotics, Chinese medicine extraction and preparation products, export pharmaceutical products.